- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07633652
Study of the Impact of Gastric Interoceptive Signals on the Body Schema Via the Water Load Test II ( GIBS) (GIBS)
June 4, 2026 updated by: Centre Hospitalier Metropole Savoie
Study of the Impact of Gastric Interoceptive Signals on the Body Schema Via the Water Load Test II
The aim of this study was to evaluate whether gastric interoceptive information has a direct impact on the motor and tactile dimensions of the body schema.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
108
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chambéry, France
- Université Savoie Mont-Blanc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy Volunteers without pathology
Exclusion Criteria:
- pregnant,
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: body schema during waterload test II
waterload test II
|
SKIN test
test MOVE
water load test II
Water load test questionnary
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
modification of the body schema in its motor and tactile dimensions
Time Frame: before and within 10 minutes after gastric interoceptive activation task (day 1)
|
The primary endpoint is composite and corresponds to the two differences in SKIN and MOVE scores, measured before and after the gastric interoceptive activation task, which assess the integrity of the body pattern.
|
before and within 10 minutes after gastric interoceptive activation task (day 1)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 4, 2025
Primary Completion (Actual)
October 2, 2025
Study Completion (Actual)
October 2, 2025
Study Registration Dates
First Submitted
April 4, 2025
First Submitted That Met QC Criteria
June 4, 2026
First Posted (Actual)
June 8, 2026
Study Record Updates
Last Update Posted (Actual)
June 8, 2026
Last Update Submitted That Met QC Criteria
June 4, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHMS24003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.